KDDD (Kyoto Drug Discovery and Development) is a spin-off company from Kyoto University. Our project is based on a result of research by Department of Ophthalmology Kyoto University and Graduate School of Biostudies. We sincerely aim to develop an innovative agent effective for various INCURABLE or INTRACTABLE eye diseases, especially CRAO, Retinal Pigmentosa, AMD and Glaucoma.
Drug development for neurodegenerative diseases.
A startup from Tokushima University providing genome-editing-based precision breeding services for agriculture and livestock, as well as contract testing for researchers. It accelerates industrial breeding and contributes to solving challenges through the power of biology.
Leveraging world-leading autophagy measurement technology, we provide end-to-end solutions from material evaluation and supplement/cosmetic development to drug discovery research. A startup demonstrating results in international competitions, aiming for the societal implementation of extended healthy lifespans.
Salus Laboratory is a startup company established in January 2022 as a venture originating from Osaka Metropolitan University. Based on research and development of plant-derived functional materials, the company promotes the development and commercialization of multifunctional foods in the health and beauty fields. Guided by scientific evidence, we aim to create products that support cognitive health and extend healthy life expectancy. Our mission is to contribute to healthy longevity by scientifically advancing the concept of “food as medicine.”